Список проголосовавших за комментарий " On The Wires<ul><li>Biocept (<strong>BIOC</strong>) announced a collaboration with Catalyst Pharmaceuticals for the provision of Biocept's Target Selector platform to screen patients diagnosed with LEMS for early onset or recurrence of small cell lung cancer (SCLC). Specifically, Biocept's liquid biopsy tests will be offered by Catalyst Pharmaceuticals at no cost to all patients enrolled in its ongoing Phase III clinical trial designed to demonstrate the safety and efficacy of Firdapse (amifampridine phosphate) for the treatment of LEMS. These patients will also have access to Biocept's liquid biopsy testing in the long-term extension study phase of the trial allowing for testing every six months for up to two years to monitor for early signals of SCLC.</li><li>Aytu BioScience (<strong>AYTU</strong>) announced the publication of a peer-reviewed journal article demonstrating the clinical utility of the Company's MiOXSYS System for assessing the level of oxidative stress in semen as an aid in the diagnosis of infertility in men. The article, titled, «Clinical Relevance of Oxidation-Reduction Potential in the Evaluation of Male Infertility,» will be published in the high profile medical journal Urology, the «Gold Journal», and is currently available online ahead of print.</li><li>Milacron Holdings Corp. (<strong>MCRN</strong>) announced that its DME product brand, a leader in mold components, molding supplies and industrial supplies, has partnered with Linear AMS (a Moog Company) to offer metal 3D printed Conformal Cooling products to help improve productivity in the molding industry.</li><li>Axcelis Technologies (<strong>ACLS</strong>) announced that it has received orders for multiple Purion XE high energy systems from a leading chip manufacturer in the Asia Pacific region. The new systems will be deployed across multiple fabs and will be used to support high volume production of 300mm memory and 200mm mature process technology. The systems are scheduled to ship in the first quarter.</li><li>First Insight announced an agreement with Pier 1 Imports (<strong>PIR</strong>). Using First Insight's consumer-driven predictive analytics, Pier 1 Imports will be able to more quickly and accurately make design, buying and pricing decisions for its furniture, tabletop items, decorative accessories and seasonal décor categories, as well as evaluate opportunities for new product launches.</li></ul>"